ALX Oncology Holdings Inc.ALXONASDAQ
Loading
Operating Cash Flow Growth AcceleratingAccelerating
Percentile Rank100
Studio
Year-over-Year Change

Year-over-year operating cash flow growth rate

Latest
30.98%
↑ 184% vs avg
Percentile
P100
Near historical high
Streak
2 yr
Consecutive growthAccelerating
Average
-36.78%
Historical baseline
PeriodValue
202530.98%
20246.48%
2023-46.11%
2022-31.02%
2021-77.86%
2020-168.71%
2019-8.03%
20180.00%